Drug application
CORSYM (CHLORPHENIRAMINE POLISTIREX, PHENYLPROPANOLAMINE POLISTIREX)
Drugs@FDA NDA 018050 · UCB INC
Key facts
| Drug name | CORSYM |
|---|---|
| Active ingredients | CHLORPHENIRAMINE POLISTIREX, PHENYLPROPANOLAMINE POLISTIREX |
| Application type | NDA |
| Application number | 018050 |
| Company | UCB INC |
| Dosage forms | SUSPENSION, EXTENDED RELEASE, ORAL |
| Strength | EQ 4MG MALEATE/5ML;EQ 37.5MG HCL/5ML |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission class | Type 5 - New Formulation or New Manufacturer |
| Latest submission status date | Jan 4, 1984 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.